Literature DB >> 24084193

Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus.

Huang-I Liao1, Chun-Chieh Wang2, Kuo-Cheng Wei1, Cheng-Nen Chang1, Yung-Hsin Hsu1, Shih-Tseng Lee1, Yin-Cheng Huang1, Hsien-Chih Chen3, Peng-Wei Hsu4.   

Abstract

Radiosurgery has been proven to be an effective treatment for residual or recurrent pituitary adenomas after surgery. However, it causes severe complications when the optic apparatus is irradiated over the tolerance dose. In this study, we analyzed the feasibility of fractionated stereotactic radiosurgery to treat pituitary tumors close to the optic apparatus. Thirty-four patients from June 2006 to June 2011 with recurrent or residual pituitary adenomas close to (<3 mm) the optic apparatus were treated with fractionated stereotactic radiosurgery. Three fractions with a total dose of 2100 cGy were applied to the tumors. Imaging, examination of vision, and estimation of hormone level were regularly performed before and after radiosurgery. The mean tumor volume before fractioned stereotactic radiosurgery was 5.06±3.08 cm3 (range: 0.82-12.69 cm3). After a mean follow up of 36.8±15.7 months (range: 16-72 months), tumor size was reduced in seven (20.6%) patients and remained the same in the other 27 (79.4%) patients. Vision was improved in one patient and remained stable in the rest. Only one patient developed transient post-treatment diplopia. This study suggests that fractionated stereotactic radiosurgery is safe for treating pituitary adenomas close to the optic apparatus. Studies with more patients and longer follow-up are required to draw definite conclusions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fractionation; Optic neuropathy; Pituitary adenoma; Radiation; Radiosurgery; Stage

Mesh:

Year:  2013        PMID: 24084193     DOI: 10.1016/j.jocn.2013.03.024

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  16 in total

Review 1.  Updates in outcomes of stereotactic radiation therapy in acromegaly.

Authors:  Monica Livia Gheorghiu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.

Authors:  Alexander D Sherry; Mohamed H Khattab; Mark C Xu; Patrick Kelly; Joshua L Anderson; Guozhen Luo; Andrea L Utz; Lola B Chambless; Anthony J Cmelak; Albert Attia
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

3.  Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas.

Authors:  Luigi Albano; Marco Losa; Francesco Nadin; Lina Raffaella Barzaghi; Veronica Parisi; Antonella Del Vecchio; Angelo Bolognesi; Pietro Mortini
Journal:  Endocrine       Date:  2019-02-23       Impact factor: 3.633

Review 4.  Target delineation and optimal radiosurgical dose for pituitary tumors.

Authors:  Giuseppe Minniti; Mattia Falchetto Osti; Maximillian Niyazi
Journal:  Radiat Oncol       Date:  2016-10-11       Impact factor: 3.481

5.  Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Rawee Ruangkanchanasetr; Pornpan Yongvithisatid
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

6.  Gamma Knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas.

Authors:  Lifeng Zhang; Wei Chen; Chang Ding; Yanjia Hu; Yuan Tian; Huiyang Luo; Jing Chen
Journal:  J Neurooncol       Date:  2021-02-27       Impact factor: 4.130

7.  Safety and efficacy of repeat radiosurgery for acromegaly: an International Multi-Institutional Study.

Authors:  Clayton E Alonso; Adomas Bunevicius; Daniel M Trifiletti; James Larner; Cheng-Chia Lee; Fu-Yuan Pai; Roman Liscak; Mikulas Kosak; Hideyuki Kano; Nathaniel D Sisterson; David Mathieu; L Dade Lunsford; Jason P Sheehan
Journal:  J Neurooncol       Date:  2019-09-20       Impact factor: 4.130

Review 8.  Management of nonfunctioning pituitary tumors: radiotherapy.

Authors:  Giuseppe Minniti; John Flickinger; Barbara Tolu; Sergio Paolini
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 9.  Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas.

Authors:  Giuseppe Minniti; Enrico Clarke; Claudia Scaringi; Riccardo Maurizi Enrici
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-14

Review 10.  STEREOTACTIC RADIATION THERAPY IN PITUITARY ADENOMAS, IS IT BETTER THAN CONVENTIONAL RADIATION THERAPY?

Authors:  M L Gheorghiu; M Fleseriu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.